Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group.
about
Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors.Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey.A headache presenting in the emergency room, a clinical manifestation of an unfortunate diagnosis (grade III left frontal anaplastic ependymoma with 1p deletion).Pediatric neurosurgery-science, art, and humility: reflection of personal experience.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesThe current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Fractionated stereotactic radiosurgery for recurrent ependymoma in children.Multidisciplinary management of pediatric intracranial ependymoma.Advances in Management of Pediatric Ependymomas.Pediatric Ependymoma.Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.Ependymoma in children under the age of 3 years: a report from the Canadian Pediatric Brain Tumour Consortium.Outcomes following proton therapy for pediatric ependymoma.EANO guidelines for the diagnosis and treatment of ependymal tumors.Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas.Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas.Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
P2860
Q33894483-27D73552-414E-4635-A86E-CEC2AFD4BD0EQ33993483-DB1447FA-D671-4642-9B44-39A9D64ECDD9Q35210469-CF507596-D626-4883-93B0-E35BA8C3E5B4Q37037444-E323D0FF-772C-4753-BBA2-EC4668B3F404Q37144653-D8617E88-8225-4EF4-8FCD-04D3EDF66119Q37154646-D5231563-9FF7-41E5-A09D-928BE22F5726Q37213305-5621BCAF-344B-4CD6-96C0-F5FE9B222245Q37553466-06A19246-7BF5-4AA0-9E47-6CDED5B0D52FQ37624153-9DE4A74E-E763-4AE9-BC3F-5C3210AA33D6Q38233102-FC43F584-7479-4B58-B914-0C73E6BB549EQ38586580-4FA3BF97-8DA3-4D4C-A228-64D1285F3B19Q38616800-0D7ED98B-B8D9-405C-9C9C-C09339E80FDEQ38865516-E469F942-54D9-4E8F-8FDA-6C8218EE4553Q39249798-2FADD5E3-5D8E-4C86-81B6-E17994D83389Q47312501-6B11723A-D876-451D-BB13-5C5BD105163CQ47940473-BC781AA1-66A8-4FF6-AC7F-72BDD1A7705BQ48092422-88311CAB-8F0F-4AF4-B31E-6A02A980FB95Q50127922-C01E1643-21B8-4DC5-823F-F63558024327Q51708755-CEB1A538-D4CF-4680-94AD-B9F0BAC59C25
P2860
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@en
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@nl
type
label
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@en
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@nl
prefLabel
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@en
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@nl
P2093
P2860
P356
P1476
Phase II study of pre-irradiat ...... the Children's Oncology Group.
@en
P2093
Ann Flannery
Children's Oncology Group
Emi Holmes
Ian F Pollack
James H Garvin
Joel W Goldwein
Jonathan L Finlay
Lucy B Rorke-Adams
Michael T Selch
Mitchell S Berger
P2860
P304
P356
10.1002/PBC.24274
P577
2012-09-04T00:00:00Z